Arcadia Biosciences, Inc. (NASDAQ:RKDA – Get Free Report) was the recipient of a significant drop in short interest in the month of February. As of February 28th, there was short interest totalling 12,400 shares, a drop of 17.3% from the February 13th total of 15,000 shares. Based on an average trading volume of 1,150,000 shares, the short-interest ratio is currently 0.0 days. Approximately 0.9% of the shares of the company are short sold.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Arcadia Biosciences stock. Geode Capital Management LLC bought a new position in shares of Arcadia Biosciences, Inc. (NASDAQ:RKDA – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 12,297 shares of the basic materials company’s stock, valued at approximately $73,000. Geode Capital Management LLC owned approximately 0.90% of Arcadia Biosciences as of its most recent SEC filing. 17.73% of the stock is currently owned by hedge funds and other institutional investors.
Arcadia Biosciences Trading Up 3.9 %
Shares of NASDAQ:RKDA opened at $3.43 on Thursday. The company has a 50 day moving average of $4.40 and a 200 day moving average of $4.10. The stock has a market cap of $4.68 million, a P/E ratio of -0.80 and a beta of 0.86. Arcadia Biosciences has a 12 month low of $1.85 and a 12 month high of $10.31.
Wall Street Analysts Forecast Growth
Check Out Our Latest Stock Analysis on Arcadia Biosciences
About Arcadia Biosciences
Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
See Also
- Five stocks we like better than Arcadia Biosciences
- What Are Dividend Champions? How to Invest in the Champions
- 3 Defense Stocks Set to Benefit From Increased Military Spending
- Do ETFs Pay Dividends? What You Need to Know
- Aluminum Tariff Woes: Between 2 Stocks, 1 Shines Brighter
- How to invest in marijuana stocks in 7 stepsÂ
- Semtech Rallies on Earnings Beat—Is There More Upside?
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.